Allergan Investors Sue Board Over Tax Tab For Exec Pay

Allergan Inc.'s board of directors was hit Monday with a shareholder derivative suit alleging it issued a misleading statement asking shareholders to approve a defective executive compensation plan that cost the...

Already a subscriber? Click here to view full article